Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Brazil was one of the hardest-hit nations by the COVID-19 pandemic on a global scale, ranking among the top three countries with the highest number of cases and deaths from the novel coronavirus. Brazil’s pharmaceutical industry, ...
View more details
Mexico is the second-largest pharmaceutical market in Latin America, after Brazil, with retail drug sales of USD 7.3bn in 2019. The country has a growing and ageing population, multiple but underfunded state-run health insurance systems, ...
View more details
Argentina is the third-largest pharmaceutical market in Latin America, with retail drug sales of USD 4.7bn in 2019. The country has a large and ageing population, a relatively developed public health system, and a small but consolidated ...
View more details
In a Latin American context, Chile is not a particularly large pharmaceutical and healthcare market, since its population is relatively small and healthy in terms of incidence of communicable diseases. However, the country’s changing ...
View more details
In Q3 2020, manufacturing operations in China were completely resumed, and most of the pharmaceutical companies increased their production to meet the growing demand. The demand for COVID-19 related drugs, protective ...
View more details
In the third quarter of 2020, China’s healthcare sector managed to recover from the challenging months of the COVID-19 outbreak in the first half of the year. Nevertheless, COVID-19 continued to affect the ...
View more details
Russia’s pharma and healthcare sector holds significant growth potential, stemming from the country’s large and aging population. Russia is home to largest pharmaceutical market in Central and Eastern Europe and is a ...
View more details
In the second quarter 2020, China’s healthcare sector continued be challenged by the COVID-19 pandemic. As the coronavirus has been affecting the socio-economic reality in the country, in July 2020 China’s State Council released ...
View more details
Healthcare remains in inadequate supply throughout most of the SEA region. The shortage is especially evident in healthcare human resources; for instance, apart from Malaysia and China, all the countries in the SEA region have fewer than 1 physician ...
View more details
In early 2020, a worldwide outbreak of coronavirus occurred, affecting the global socio-economic reality. COVID-19 posed a particular challenge to the healthcare industry. Since the pandemic started in Wuhan, Hubei province, China took a leading role ...
View more details